SensoDetect technology in new doctoral thesis at Lund University

PhD student at the child and adolescent psychiatry at the University of Lund and chief physician Emma Claesdotter, defended on Friday her thesis "Auditory Brainstem Response (ABR) and Cambridge Neurophysiological Test Automated Battery (CANTAB) as Objective Support in Diagnosing Childhood ADHD and ASD". Claesdotter has examined children and adolescents with ADHD and ASD with SensoDetect technology in three studies.

Today's diagnosis of ADHD and autism (ASD) is based on the patient's medical history, psychological testing and assessment forms. These methods are not objective and can be affected by, for example, psychosocial factors. Emma Claesdotter has in the three studies examined children and adolescents with ADHD and ASD using SensoDetect technology. Associate Professor Tommy Lewander from  Uppsala University was the opponent. The markers from Emma Claesdotter studies will be evaluated further in a blind study by the research team. 

-ABR-technology is an exciting area and there is great need of objective markers of these situations (ADHD and ASD), says Emma Claesdotter, PhD and Cheif physician at Lund University Hospital, Sweden.  

- It is very positive for both SensoDetect and of course for Emma that her doctoral thesis now is approved. It strengthens and increases the evidence and further possibilities’, Says CEO Johan Olson, SensoDetect AB (publ.) 

Johan Olson

VD, SensoDetect Aktiebolag (publ)

Phone: +46 705 424600

e-mail: jo@sensodetect.com

 

Jan Andersson

Chairman of the board, SensoDetect Aktiebolag (publ)

Phone: +46 793 472280

E-mail: jan@sensodetect.com

This information is information that SensoDetect AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on October 24 2017.

SensoDetect highlights through patented equipment brain stem responses to audio stimuli in order to provide health care clear anomalies and patterns for use primarily within psychiatry. The goal is to increase efficiency in Psychiatry and thus the benefits for health care, society, patients and relatives.

Our Mission
Improve the lives of people with mental illness
Our Vision
Making ABR profiling tests with SensoDetect technology an integral part of setting diagnosis for mental illness
Our Value Proposition:
SensoDetect provides a complete audiogram for the brainstem, helping health care professional to set psychiatric diagnoses objectively and
cost effectively. This unique offering improves patients’ quality of life and reduces the economic impact on the health care system and society

Tags:

Subscribe

Documents & Links

Quotes

ABR-technology is an exciting area and there is great need of objective markers of these situations (ADHD and ASD)
Emma Claesdotter, PhD and Cheif physician at Lund University Hospital, Sweden
It is very positive for both SensoDetect and of course for Emma that her doctoral thesis now is approved. It strengthens and increases the evidence and further possibilities’
CEO Johan Olson, SensoDetect AB (publ.)